We are live on
!
Find out more
Edwards Lifesciences
407 hedge funds and large institutions have $6.52B invested in Edwards Lifesciences in 2013 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 111 increasing their positions, 174 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
38.54% more ownership
Funds ownership: 506.22% → 544.76% (+39%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% less funds holding
Funds holding: 409 → 407 (-2)
1% less capital invested
Capital invested by funds: $6.58B → $6.52B (-$58.1M)
1% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 67
8% less call options, than puts
Call options by funds: $81.4M | Put options by funds: $88.8M
36% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 174
Holders
407
Holders Change
-2
Holders Change %
-0.49%
% of All Funds
11.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
66
Increased
111
Reduced
174
Closed
67
Calls
$81.4M
Puts
$88.8M
Net Calls
-$7.36M
Net Calls Change
-$75.9M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$270M |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$186M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$126M |
| 4 |
JP
Jana Partners
New York
|
+$105M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$52.3M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$101M |
| 2 |
BAMCO Inc
New York
|
-$43.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$42.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$42.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$41.1M |
